Bionano Genomics, Inc. fell 10.6% on Wednesday, November 11, 2026, on 583,677 shares. Headlines around the move:
Bionano Genomics, Inc. (BNGO:NASDAQ) closed at $1.10 on November 11, 2026, down 10.57% on the day. The stock trades 50.7% below its 52-week high of $2.23 and 10.0% above its 52-week low of $1.00. Over the past year, it lost 31.3%. Bionano Genomics, Inc. is part of the Capital Goods sector (Biotechnology: Laboratory Analytical Instruments).
In 252 trading sessions since November 11, 2025, BNGO closed higher on 102 days (40%). Its best day was March 23, 2026 (+26.96%) and its worst was March 24, 2026 (-19.18%). The stock moved 10% or more in a single session 6 times.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Find more stocks like BNGO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.